5-Bromo-6-chloro-1H-indazole-3-carbaldehyde

Catalog No.: 
ACWZVM387
CAS No.: 
1956325-18-0
Molecular Formula: 
C8H4BrClN2O
Molecular Weight: 
259.49
5-Bromo-6-chloro-1H-indazole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$134.00InquiryInquiry
250mg95%$178.00In stockInquiry
1g95%$356.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-chloro-1H-indazole-3-carbaldehyde
IUPAC Name5-bromo-6-chloro-1H-indazole-3-carbaldehyde
MDL No.MFCD29058875
Molecular FormulaC8H4BrClN2O
Molecular Weight259.49
SMILESO=CC1=NNC2=C1C=C(Br)C(Cl)=C2
InChI KeyNPUMJIWWDKUNPO-UHFFFAOYSA-N
Synonym5-Bromo-6-chloro-1H-indazole-3-carbaldehyde | 1956325-18-0 | EN300-24469795 | Z2471604418
CAS No.1956325-18-0
PubChem CID118990117

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWZVM387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZARB073 route compound structure diagram
    ACZARB0731260382-77-1In Stock
  4. Then
  5. ACWZVM387 route product structure diagram
    ACWZVM3871956325-18-0In Stock
Inquiry

2. ACWZVM387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZVM387 route product structure diagram
    ACWZVM3871956325-18-0In Stock
Inquiry

3. ACWZVM387 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZVM387 route product structure diagram
    ACWZVM3871956325-18-0In Stock
Inquiry

Comments (0)